Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
NTRA
Home
/
NTRA

NASDAQ
$386.269
$386.269

Overview

Price performance
Low
$369.51
High
$395.20
Market open. Last updated: Nov 4, 2026, 7:07 PM UTC
$
386.27
-2.36 (-0.61%)
Average, 50 days
$379.22
$267.62
Open
$393.42
Previous close
$388.63
52-week high
$437.41
Oct 6, 2026 (30 days ago)
52-week low
$181.00
Mar 27, 2026 (8 months ago)
113.41%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
55.68B
Volume
1 572 315
Total Return (3M)
40.19%
Total Return (1Y)
96.38%
105.90
Sector
Healthcare
Links
Tags
Healthcare
Medical - Diagnostics & Research
NASDAQ
US
Website
natera.com
Socials
About
Natera, Inc. is a diagnostics company focused on developing and commercializing a wide array of molecular testing services globally. Its portfolio includes several key offerings: Panorama, a non-invasive prenatal test (NIPT) that screens for chromosomal abnormalities in a fetus using a blood sample from the mother, and also determines zygosity in twin pregnancies. Vistara, designed to identify single-gene disorders by screening for specific single-gene mutations. Horizon, a comprehensive carrier screening test to determine an individual's carrier status for various genetic diseases. Spectrum, utilized during in vitro fertilization (IVF) cycles to detect chromosomal anomalies or inherited genetic conditions. Anora, a miscarriage analysis product that examines fetal chromosomes to help understand the cause of pregnancy loss. Non-invasive paternity testing, which establishes paternity during gestation using blood samples from both the pregnant mother and the alleged father. Beyond reproductive health, Natera also provides specialized tests: Signatera, a sophisticated circulating tumor DNA (ctDNA) technology capable of screening for a generic set of mutations, independent of the individual's specific tumor characteristics. Prospera, a test used to assess and monitor organ transplant rejection. Additionally, the company offers Constellation, a cloud-based software platform that provides laboratory clients with access to Natera's proprietary algorithms and bioinformatics, enabling them to validate and launch their own tests. Natera distributes its products through a direct sales team and an extensive network of approximately 100 laboratory and distribution partners. The company has strategic partnerships, including one with BGI Genomics Co., Ltd. for the development, manufacturing, and commercialization of NGS-based genetic testing assays, and another with Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. Founded in 2003, Natera, Inc. is headquartered in Austin, Texas. It was formerly known as Gene Security Network, Inc. before changing its name in 2012.

Frequently asked questions

NTRA · Natera, Inc.

01What is Natera, Inc. stock price today?

The current price of NTRA is $386.27 — it has decreased by 0.61% since the previous close. Data as of Nov 4, 2026.

02Is Natera, Inc. stock price growing?

NTRA is down 9.35% over the past week, down 5.99% over the past month and up 96.38% over the past year. The price is above its 200-day moving average of $267.62.

03What is Natera, Inc. market cap?

Natera, Inc. has a market capitalization of $55.68B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

04How volatile is NTRA stock?

In the latest trading session NTRA moved between $369.51 and $395.20, a range of 6.65% of its current price.

05What are NTRA stock 52-week high and low?

Over the past 52 weeks NTRA has traded between $181.00 and $437.41. The current price is 11.69% below its 52-week high.

Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.